In patients with advanced NSCLC, treatment with Jemperli plus chemotherapy showed promising effectiveness compared with Keytruda plus chemotherapy.
Society for Immunotherapy of Cancer | Strategic Alliance Partners
Latest from Society for Immunotherapy of Cancer
Advertisement
Advertisement
Trending on CURE
1
FDA Grants Fast Tract Designation to VT3989 for Mesothelioma
2
Body Image and Sexual Health Challenges After Breast Cancer
3
Breast Cancer Awareness Needs Action, Not Just Pink Ribbons
4
What Libtayo Means for High-Risk Cutaneous Squamous Cell Carcinoma
5
